Navigation Links
Martek Announces Second Quarter 2008 Financial Results
Date:6/4/2008

tions 14,357 8,077 27,659 12,835

Interest income (expense)

and other, net 309 (433) 526 (874)

Income before income tax

provision 14,666 7,644 28,185 11,961

Income tax provision 5,464 2,775 10,314 4,342

Net income $9,202 $4,869 $17,871 $7,619

Basic earnings per share $0.28 $0.15 $0.54 $0.24

Diluted earnings per share $0.28 $0.15 $0.54 $0.23

Shares used in computing

basic earnings per share 32,916 32,239 32,830 32,209

Shares used in computing

diluted earnings per share 33,231 32,442 33,151 32,430

Unaudited Condensed Consolidated Balance Sheets Data

April 30, October 31,

2008 2007

Assets:

Cash and cash equivalents $44,656 $16,973

Short-term investments - 4,675

Accounts receivable, net 44,593 41,643

Inventories, net 112,521 109,409

Other current assets 5,221 8,237

Property, plant and equipment, net 270,530 277,915

Deferred tax asset 43,395 51,306

Long-term auction rate security investments 14,701 -

Goodwill and other, net 84,798 86,537

Total assets $620,415 $596,695

Liabilities and stockholders' equity:

Current liabilities $43,219 $46,141

Non-current liabil
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... The report "Unmanned Ground Vehicle ... Technology, Payload, Type & by Geography - Forecasts ... unmanned ground vehicle market into various sub segments ... sizes. The report also identifies the factors driving ... along with the adoption trends. , The unmanned ...
(Date:10/18/2014)... The “Human Insulin Market- by ... Premixed), Modern Human Insulin (Rapid Acting, Long Acting, ... Tresiba, Others) - Forecast to 2018” provides a ... opportunities, current market trends, and strategies impacting the ... and forecasts of the revenue and share analysis. ...
(Date:10/18/2014)... October 18, 2014 The report ... Trends and Forecasts to 2019", analyzes the global ... order to understand the industry details such as ... across various geographic regions. , Browse 81 Market ... Slides and in-depth TOC on “1,6-Hexanediol Market by ...
(Date:10/18/2014)... The Asia-Pacific hardware encryption display market report ... analysis and forecast of revenue. This market was valued ... $51,362.6 million by 2018, at a CAGR of 58.4% ... of the Asia-Pacific hardware encryption market report, to get ... provides a glimpse of the segmentation of the market, ...
Breaking Biology Technology:Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 2Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 3Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 4Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 5Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 51,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 21,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 31,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 41,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 5The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 3
... Sigma-Aldrich (Nasdaq:,SIAL) today announced the publication of ... Journal of Visualized Experiments (JoVE).,This makes Sigma-Aldrich the ... to the traditional scientific publication process. Peer-reviewed,video protocols ... increase the,efficiency of scientific communication and with it ...
... BAX ), will host a quarterly conference call ... October 16, 2008, at,8:30 a.m. Eastern Time (7:30 a.m. ... (domestic) or 703-639-1156 (international). Please dial,into the call at ... call for the,operator to connect you., This call ...
... N.J., Sept. 17 Synvista,Therapeutics, Inc. (Amex: SYI ... posted to the Company,s Web site http://www.synvista.com . ... The team at Synvista Therapeutics has made tremendous progress ... medicine, and to redefine,the treatment of cardiovascular disease in ...
Cached Biology Technology:Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMed's Peer-Reviewed Video Journal JoVE 2Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMed's Peer-Reviewed Video Journal JoVE 3Baxter International Third Quarter 2008 Financial Results Conference Call 2Synvista Therapeutics Posts Letter to Stockholders on Web Site 2Synvista Therapeutics Posts Letter to Stockholders on Web Site 3Synvista Therapeutics Posts Letter to Stockholders on Web Site 4Synvista Therapeutics Posts Letter to Stockholders on Web Site 5Synvista Therapeutics Posts Letter to Stockholders on Web Site 6
(Date:10/15/2014)... As our ability to assess the pandemic risk from ... developments, we must not allow ourselves to become complacent ... an international consortium of scientists. , Influenza pandemics arise ... have yet to develop widespread immunity – spreads in ... in the past 100 years, the worst of which ...
(Date:10/15/2014)... have linked increased resistance to bacterial pneumonia in female ... hormone estrogen. , Females are naturally more resistant to ... scientists has shown that increased resistance to bacterial pneumonia ... oxide synthase 3 (NOS3). They also show that this ... female sex hormone estrogen. , The team, lead by ...
(Date:10/14/2014)... N.C. – Like discriminating thieves, prostate cancer tumors scavenge ... the body. But such avarice may be a fatal ... a way to kill prostate cancer cells by delivering ... selectively destroys the diseased cells brimming with the mineral, ... uses two drugs already commercially available for other uses, ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Prostate cancer's penchant for copper may be a fatal flaw 2
... inevitable climate change" How will different kinds of businesses ... and tourism -- be affected" Which state and local ... will these groups obtain the kinds of climate-change forecasts ... the uncertain decades to come" Find out at "Climate ...
... Graduate students and scientists of the Resilience and ... received a five-year, $3.2 million grant from the ... resilience, adaptation and sustainability. RAP focuses ... climate change, affect local processes, such as indigenous ...
... unfavorable environments. Struggling for oxygen and nutrients while ... cells in fact require sophisticated adaptations to survive ... to circumvent these adaptations to destroy cancer. Now, ... (UMMS), have defined a method to target and ...
Cached Biology News:Meeting real-world climate information needs of business, government 2Alaska graduate program in sustainability receives $3.2 million award 2Sidestepping cancer's chaperone 2
The epitope is specific for TASK and is not present in any other known proteins tested so far.,SPECIES REACTIVITIES: The epitope is also highly conserved between mouse and rat (17/18 residues iden...
Rat Antibody to Kinase Suppressor Of Ras Recognises the kinase suppressor of Ras (KSR). Immunogen: Recombinant human KSR protein Specificity: human kinase supressor of Ras...
Request Info...
Form: Ready to use Applications: ELISA...
Biology Products: